ORTOMA AB B Cash Flow Conversion Efficiency
ORTOMA AB B cash flow conversion efficiency. Based on the latest financial reports, ORTOMA AB B (82Y) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.13 Million ≈ $-20.03 Million USD) by net assets (€142.72 Million ≈ $166.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ORTOMA AB B (2021–2025)
Cash flow conversion efficiency of ORTOMA AB B from 2021 to 2025. This chart illustrates how ORTOMA AB B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 82Y share price today for real-time trading data and today's change.
ORTOMA AB B Cash Flow Conversion Ratio Explained
ORTOMA AB B cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ORTOMA AB B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ORTOMA AB B ranked by their cash flow conversion efficiency. Also see ORTOMA AB B (82Y) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prodigy Public Company Limited
BK:PDG
|
0.055x |
|
Shinfox Energy Co Ltd
TW:6806
|
0.649x |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
-0.169x |
|
Panstar Enterprise Co.Ltd
KQ:054300
|
-0.018x |
|
Forsee Power SAS
PA:FORSE
|
0.022x |
|
Bragg Gaming Group Inc
TO:BRAG
|
0.063x |
|
Nano Labs Ltd
NASDAQ:NA
|
-0.072x |
|
Nureca Limited
NSE:NURECA
|
0.022x |
Annual Cash Flow Conversion Efficiency for ORTOMA AB B (2021–2025)
The table below shows the annual cash flow conversion efficiency of ORTOMA AB B from 2021 to 2025. Review ORTOMA AB B (82Y) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €142.72 Million ≈ $166.85 Million |
€6.04 Million ≈ $7.06 Million |
0.042x | +131.12% |
| 2024-12-31 | €161.91 Million ≈ $189.29 Million |
€-22.01 Million ≈ $-25.73 Million |
-0.136x | -276.65% |
| 2023-12-31 | €173.54 Million ≈ $202.88 Million |
€13.35 Million ≈ $15.61 Million |
0.077x | +206.13% |
| 2022-12-31 | €114.29 Million ≈ $133.62 Million |
€-8.29 Million ≈ $-9.69 Million |
-0.073x | +37.94% |
| 2021-12-31 | €130.04 Million ≈ $152.03 Million |
€-15.19 Million ≈ $-17.76 Million |
-0.117x | -- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more